Jean‐Charles Soria

机构：UniCancer Group · ORCID：0000-0001-9597-0701

发表论文 1601 篇 · 总被引 93216 次 · h-index 130

代表论文

Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges (2023 · Nature Reviews Clinical Oncology · 被引 202)
Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision? (2023 · ESMO Open · 被引 45)
The search for therapeutic targets in lung cancer: Preclinical and human studies of carcinoembryonic antigen-related cell adhesion molecule 5 expression and its associated molecular landscape (2023 · Lung Cancer · 被引 24)
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study (2023 · ESMO Open · 被引 20)
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial (2023 · British Journal of Cancer · 被引 10)
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials (2024 · npj Precision Oncology · 被引 9)